Dr. Henry Eric Degroot, MD

Dr. Degroot practices at San Francisco VA Medical Center in San Francisco, California, part of Veterans Health Administration.

Dr. Degroot's NPI, 1346260411, was assigned on July 20, 2006. Dr. Degroot graduated from Indiana University School Of Medicine in 1994. Dr. Degroot holds California license A55665.

Dr. Degroot's primary practice is San Francisco VA Medical Center, at 4150 Clement Street, San Francisco, CA 94121 in San Francisco County. The practice phone is (415) 221-4810.

Dr. Degroot's primary practice is San Francisco VA Medical Center in San Francisco, California, part of Veterans Health Administration. Dr. Degroot is also affiliated with Adventist Health Ukiah Valley. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Degroot to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Degroot practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Degroot's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Degroot is board certified in dermatology by the American Board of Dermatology. Dr. Degroot is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Degroot treats.

CMS data shows 11,883 Medicare services from Dr. Degroot across 31 procedure codes in 2024, for 1,148 Medicare patients. Medicare paid $470,072 for them. Every service was in an office.

CMS counts 1,148 Medicare patients who saw Dr. Degroot in 2024. The largest group is 65 to 74, with 518 patients. 66% of them have high cholesterol, and 61% have high blood pressure. 12% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Degroot's median patient age at 68, with 50% women.

In 2024, Dr. Degroot wrote 1,220 Medicare Part D claims for 469 patients. 89% of them were for generic drugs. CMS names the drug for 1,114 of them, across 25 drugs with 11 or more claims each, at $617,820 in total drug cost. In 2023, CMS named 1,001 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Degroot for performance year 2024, reported as part of a group. Dr. Degroot accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Degroot as offering telehealth. CMS counts 761 procedures of skin biopsy by Dr. Degroot, more than 98% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Degroot in 2007. Dr. Degroot's most frequent co-authors are Patricia Dahl, MD, Gary M. Green, MD and Edith Rachel Lederman, MD, MPH.

CMS Open Payments shows 797 general payments to Dr. Degroot from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $3,930.

Dmand AI lists 3 awards for Dr. Degroot, most recently Regional Top Doctor in 2014.

Dr. Degroot graduated from Indiana University School Of Medicine in 1994. Dr. Degroot is a member of AAD.

Dr. Degroot is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.